Antimicrobial resistance (AMR) is a global health threat, urgently requiring novel compounds with new targets. One emerging strategy is the development of ‘antibiotic adjuvants’ that inhibit the mutagenic SOS response in bacteria, thus prolonging antibiotic efficacy. OXF‑077 is a potent SOS-response...
ORGANISM(S): Staphylococcus aureus